↓ Skip to main content

Rituximab for thyroid-associated ophthalmopathy

Overview of attention for article published in Cochrane database of systematic reviews, May 2013
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 tweeters

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
68 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Rituximab for thyroid-associated ophthalmopathy
Published in
Cochrane database of systematic reviews, May 2013
DOI 10.1002/14651858.cd009226.pub2
Pubmed ID
Authors

Neda Minakaran, Daniel G Ezra

Abstract

Thyroid associated ophthalmopathy (TAO) is the most frequent extrathyroidal manifestation of Graves' disease, affecting up to 50% of patients, and has a great impact on quality of life. Rituximab is a human/murine chimeric monoclonal antibody that targets CD20, a transmembrane protein expressed on the surface of pre-B and mature B lymphocytes, but not on stem cells, pro-B lymphocytes or plasma cells. Preliminary work has shown that blocking the CD20 receptor on B-lymphocytes with rituximab affects the clinical course of TAO, by reducing inflammation and the degree of proptosis.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Chile 1 1%
Colombia 1 1%
Unknown 66 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 22%
Student > Master 9 13%
Other 6 9%
Student > Bachelor 6 9%
Student > Ph. D. Student 5 7%
Other 15 22%
Unknown 12 18%
Readers by discipline Count As %
Medicine and Dentistry 39 57%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Nursing and Health Professions 4 6%
Psychology 2 3%
Agricultural and Biological Sciences 1 1%
Other 3 4%
Unknown 15 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 June 2013.
All research outputs
#6,596,538
of 12,527,219 outputs
Outputs from Cochrane database of systematic reviews
#7,004
of 8,923 outputs
Outputs of similar age
#59,382
of 148,453 outputs
Outputs of similar age from Cochrane database of systematic reviews
#82
of 133 outputs
Altmetric has tracked 12,527,219 research outputs across all sources so far. This one is in the 46th percentile – i.e., 46% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 148,453 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 133 others from the same source and published within six weeks on either side of this one. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.